收费全文 | 199525篇 |
免费 | 3826篇 |
国内免费 | 1871篇 |
耳鼻咽喉 | 1273篇 |
儿科学 | 6898篇 |
妇产科学 | 3256篇 |
基础医学 | 19156篇 |
口腔科学 | 2088篇 |
临床医学 | 15624篇 |
内科学 | 33714篇 |
皮肤病学 | 956篇 |
神经病学 | 17500篇 |
特种医学 | 9754篇 |
外国民族医学 | 12篇 |
外科学 | 30937篇 |
综合类 | 7477篇 |
现状与发展 | 7篇 |
一般理论 | 2篇 |
预防医学 | 20023篇 |
眼科学 | 3270篇 |
药学 | 12203篇 |
34篇 | |
中国医学 | 2910篇 |
肿瘤学 | 18128篇 |
2024年 | 52篇 |
2023年 | 556篇 |
2022年 | 955篇 |
2021年 | 1549篇 |
2020年 | 1388篇 |
2019年 | 1027篇 |
2018年 | 22896篇 |
2017年 | 18340篇 |
2016年 | 20322篇 |
2015年 | 2144篇 |
2014年 | 2314篇 |
2013年 | 2094篇 |
2012年 | 8845篇 |
2011年 | 22919篇 |
2010年 | 20094篇 |
2009年 | 12568篇 |
2008年 | 20569篇 |
2007年 | 22861篇 |
2006年 | 1571篇 |
2005年 | 3087篇 |
2004年 | 4169篇 |
2003年 | 5317篇 |
2002年 | 3360篇 |
2001年 | 1036篇 |
2000年 | 910篇 |
1999年 | 604篇 |
1998年 | 470篇 |
1997年 | 503篇 |
1996年 | 308篇 |
1995年 | 298篇 |
1994年 | 252篇 |
1993年 | 146篇 |
1992年 | 200篇 |
1991年 | 205篇 |
1990年 | 196篇 |
1989年 | 148篇 |
1988年 | 112篇 |
1987年 | 105篇 |
1986年 | 66篇 |
1985年 | 63篇 |
1984年 | 46篇 |
1983年 | 34篇 |
1982年 | 34篇 |
1980年 | 43篇 |
1938年 | 60篇 |
1937年 | 25篇 |
1935年 | 22篇 |
1934年 | 30篇 |
1932年 | 56篇 |
1930年 | 46篇 |
Aim
Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an immune inhibitory receptor which is expressed within most types of hematopoietic cells and negatively regulates immune responses. Recently, we found LAIR-1 expression to be present within tumors of nonhematopoietic lineages. However, the roles of LAIR-1 in hepatocellular carcinoma (HCC) have yet to be examined. The purpose of this study was to investigate the expression of LAIR-1 in HCC tissue and assess its clinical significance at this site.Materials and methods
Expression levels of LAIR-1 within HCC samples collected from 90 patients and compared with that of slides of normal liver tissue collected from 9 non-HCC patients were measured by immunohistochemistry using tissue microarrays. A semiquantitative score was assigned, as was based on staining intensity and percent of positive cells and a Spearman Rank correlation test was used to assess any potential significant correlations between LAIR-1 expression and clinicopathological factors. Overall survival analysis was performed using the Kaplan-Meier and Log Rank statistical test.Results
LAIR-1 expression was detected in cancer tissue and adjacent tumor tissue, but not in normal liver tissue. The percent of LAIR-1-positive expression in cancer tissue of HCC samples was 97.78% (88/90) while that in adjacent tumor tissue was 96.67% (87/90). Significantly greater expression levels of LAIR-1 were obtained from cancer tissue (Mean?±?SD?=?5.722?±?2.145) than that in adjacent tumor tissue (4.141?±?1.486). In addition, LAIR-1 expression was found to be significantly correlated with pathological grade of HCC, T stage, and age. Expression levels of LAIR-1 were related with worse overall survival rates of HCC patients, especially in HCC patients with hepatic cirrhosis.Conclusion
Results of this study show that LAIR-1 is expressed in HCC tissues and that high levels of LAIR-1 expression are associated with the poor cancer differentiation. In addition, overexpression of LAIR-1 was significantly associated with worse overall survival in the patients with HCC. These data suggest that LAIR-1 may be an independent predictor for clinical outcomes in patients with HCC. 相似文献Materials and methods: From 2011 to 2013, we recruited 231 primary cerebral infarct patients that were divided to a Hhcy group (n?=?105) and a control group (n?=?126) according to plasma homocysteinemia (Hcy) levels exceeding 15?μmol/L. In this prospective study, risk factors such as gender, age, blood lipid and glucose levels, history of diabetes, high blood pressure, smoking habits and plasma Hhcy levels were determined. A three-year follow-up compared differences in cerebral infarction recurrence rates. Statistical analyses identified whether plasma Hhcy levels were an independent risk factor for recurrent cerebral infarction.
Results: Triglyceride and low-density lipoprotein (LDL) levels in the Hhcy group were significantly higher than controls, and cerebral infarct recurrence rates in the Hhcy group exceeded control subject rates through the three-year follow-up (p?=?.021, p?=?.036 and p?=?.025). Cox proportional hazards modeling showed that elevated Hhcy levels (hazard ratio [HR]?=?3.062, p?<?.001), increased age (HR?=?1.069, p?<?.01), circulating triglyceride levels (HR?=?1.686, p?=?.048), and relative National Institutes of Health Stroke (NIHSS) score (HR?=?1.068, p?=?.016) were risk factors for recurrent cerebral infarction.
Conclusions: Level of Hhcy was a risk factor for recurrent cerebral infarction. Further, particular demographic and clinical outcomes including age, relative NIHSS scores, and circulating triglyceride levels were markedly associated with the occurrence of cerebral infarction. 相似文献